Preparing health systems in Southeast and East Asia for new paradigms of care/personalized medicine in cancers: are health systems ready for evolving cancer management?

Jeremy F.Y. Lim, Matt Zafra, Joseph D. Mocanu, Indira Umareddy, Gilberto de Lima Lopes, Roger Foo, Anand Jha, Lucy Hickinbotham

Research output: Contribution to journalArticlepeer-review

Abstract

Roughly 9.7 million people are living with cancer in East and Southeast Asia. Once viewed as a virtual death sentence, cancer is increasingly treatable with the advent of personalized medicine, and even preventable in some cases through genetic screening and certain lifestyle changes. With the increasing prevalence and application of personalized medicine and diagnosis, more and more cancers will become ‘rare’. Thus, it is thus important to promote societal awareness and discussion around how best to manage care of rare cancers today. Are health systems in Asia prepared for this paradigm shift in oncology care? Is there a functioning ecosystem, which encompasses information, patient support, genetic screening of families and surveillance for other cancers? What needs to be done today to prepare for tomorrow’s reality? This article examines Asian health systems state of readiness and how they can prepare for the anticipated demand for access to personalized medicine in cancer care and suggests opportunities for expanded efforts to address resource gaps and leverage individual country expertise at a regional level.

Original languageEnglish (US)
Pages (from-to)268-286
Number of pages19
JournalJournal of Asian Public Policy
Volume10
Issue number3
DOIs
StatePublished - Sep 2 2017

Keywords

  • Cancer
  • East Asia
  • Southeast Asia
  • personalized medicine
  • rare cancer
  • rare disease

ASJC Scopus subject areas

  • Sociology and Political Science
  • Public Administration

Fingerprint

Dive into the research topics of 'Preparing health systems in Southeast and East Asia for new paradigms of care/personalized medicine in cancers: are health systems ready for evolving cancer management?'. Together they form a unique fingerprint.

Cite this